Robert Wilson

Summary

Affiliation: Royal Brompton Hospital
Country: UK

Publications

  1. ncbi request reprint A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes
    Robert Wilson
    Royal Brompton Hospital, London, England
    Clin Ther 24:639-52. 2002
  2. ncbi request reprint Oral gemifloxacin once daily for 5 days compared with sequential therapy with i.v. ceftriaxone/oral cefuroxime (maximum of 10 days) in the treatment of hospitalized patients with acute exacerbations of chronic bronchitis
    R Wilson
    Royal Brompton Hospital, London, U K
    Respir Med 97:242-9. 2003
  3. ncbi request reprint Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis
    Robert Wilson
    Royal Brompton Hospital, London, UK
    Chest 125:953-64. 2004
  4. pmc Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results
    Robert Wilson
    Host Defence Unit, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK
    Eur Respir J 40:17-27. 2012
  5. doi request reprint The use of moxifloxacin for acute exacerbations of chronic obstructive pulmonary disease and chronic bronchitis
    Robert Wilson
    Royal Brompton Hospital, London, UK
    Expert Rev Respir Med 6:481-92. 2012
  6. doi request reprint Cyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosis
    Gregory J Keir
    Royal Brompton Hospital, London, UK
    Thorax 69:287-8. 2014
  7. pmc Newer fluoroquinolones in the treatment of acute exacerbations of COPD
    Amit Patel
    Royal Brompton Hospital, London, UK
    Int J Chron Obstruct Pulmon Dis 1:243-50. 2006
  8. doi request reprint Respiratory infection in noncystic fibrosis bronchiectasis
    Zaid Zoumot
    Host Defence Unit, Royal Brompton Hospital, London, UK
    Curr Opin Infect Dis 23:165-70. 2010
  9. pmc A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology
    Robert Wilson
    Host Defence Unit, Royal Brompton Hospital, London, England, UK
    Int J Chron Obstruct Pulmon Dis 6:373-83. 2011
  10. pmc Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study
    Robert Wilson
    Host Defence Unit, Royal Brompton Hospital, London, UK
    Eur Respir J 41:1107-15. 2013

Collaborators

Detail Information

Publications18

  1. ncbi request reprint A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes
    Robert Wilson
    Royal Brompton Hospital, London, England
    Clin Ther 24:639-52. 2002
    ..Gemifloxacin is an enhanced-affinity quinolone with potent activity against lower respiratory tract pathogens...
  2. ncbi request reprint Oral gemifloxacin once daily for 5 days compared with sequential therapy with i.v. ceftriaxone/oral cefuroxime (maximum of 10 days) in the treatment of hospitalized patients with acute exacerbations of chronic bronchitis
    R Wilson
    Royal Brompton Hospital, London, U K
    Respir Med 97:242-9. 2003
    ..A 5-day course of oral gemifloxacin was shown by this study to be at least equivalent to sequential i.v. ceftriaxone/cefuroxime axetil (for up to 10 days) in patients with AECB who require hospital treatment...
  3. ncbi request reprint Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis
    Robert Wilson
    Royal Brompton Hospital, London, UK
    Chest 125:953-64. 2004
    ..To compare the effectiveness of oral moxifloxacin with standard antibiotic therapy in acute exacerbation of chronic bronchitis (AECB)...
  4. pmc Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results
    Robert Wilson
    Host Defence Unit, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK
    Eur Respir J 40:17-27. 2012
    ..The MAESTRAL study showed that moxifloxacin was as effective as amoxicillin/clavulanic acid in the treatment of outpatients with AECOPD. Both therapies were well tolerated...
  5. doi request reprint The use of moxifloxacin for acute exacerbations of chronic obstructive pulmonary disease and chronic bronchitis
    Robert Wilson
    Royal Brompton Hospital, London, UK
    Expert Rev Respir Med 6:481-92. 2012
    ..Moxifloxacin is a quinolone antibiotic and is one of the treatment options. This article discusses pathophysiology of these diseases, moxifloxacin clinical studies and appropriate use of moxifloxacin...
  6. doi request reprint Cyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosis
    Gregory J Keir
    Royal Brompton Hospital, London, UK
    Thorax 69:287-8. 2014
    ..We report a treatment regimen of cyclical caspofungin infusions in 10 patients with sarcoidosis and worsening CPA despite oral triazoles. ..
  7. pmc Newer fluoroquinolones in the treatment of acute exacerbations of COPD
    Amit Patel
    Royal Brompton Hospital, London, UK
    Int J Chron Obstruct Pulmon Dis 1:243-50. 2006
    ..Recent antibiotic trials have compared fluoroquinolones with "standard" antibiotics and found, in the main, longer exacerbation-free intervals and better bacterial eradication rates in those treated with fluoroquinolones...
  8. doi request reprint Respiratory infection in noncystic fibrosis bronchiectasis
    Zaid Zoumot
    Host Defence Unit, Royal Brompton Hospital, London, UK
    Curr Opin Infect Dis 23:165-70. 2010
    ..We highlight some of the main developments in the investigation and management of bronchiectasis, a condition causing susceptibility to airway infections and in more severe cases chronic bronchial suppuration...
  9. pmc A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology
    Robert Wilson
    Host Defence Unit, Royal Brompton Hospital, London, England, UK
    Int J Chron Obstruct Pulmon Dis 6:373-83. 2011
    ..Patients are stratified according to oral corticosteroid use to control their effect across antibiotic treatment arms. Secondary endpoints include quality of life, symptom assessments and health care resource use...
  10. pmc Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study
    Robert Wilson
    Host Defence Unit, Royal Brompton Hospital, London, UK
    Eur Respir J 41:1107-15. 2013
    ..Ciprofloxacin DPI 32.5 mg twice daily for 28 days was well tolerated and achieved significant reductions in total bacterial load compared with placebo in subjects with non-cystic fibrosis bronchiectasis...
  11. doi request reprint Pulmonary hypertension in patients with bronchiectasis: prognostic significance of CT signs
    Anand Devaraj
    Department of Radiology, Royal Brompton Hospital, Sydney St, London, SW3 6NP, UK
    AJR Am J Roentgenol 196:1300-4. 2011
    ..The purpose of this study was to evaluate the association between pulmonary hypertension estimated with CT and outcome among patients with bronchiectasis...
  12. ncbi request reprint Pharmacotherapy for bronchiectasis
    Michael R Loebinger
    Royal Brompton Hospital, Host Defence Unit, Fulham Road, London, SW3 6NP, UK
    Expert Opin Pharmacother 8:3183-93. 2007
    ..This article discusses the management of bronchiectasis with particular reference to the pathophysiological processes involved in the condition. It then looks at the available evidence supporting such a management plan...
  13. ncbi request reprint In vitro models of infection I--human respiratory tissue organ culture
    Andrew M Middleton
    Department of Microbiology, Royal Brompton Hospital, Host Defense Unit, Imperial College School of Science, Technology and Medicine, National Heart and Lung Institute, London, United Kingdom
    Methods Mol Med 71:277-95. 2003
  14. ncbi request reprint MOSAIC acronym
    Robert Wilson
    Chest 126:1708. 2004
  15. ncbi request reprint Endothelial dysfunction in patients with recent myocardial infarction and hyperhomocysteinaemia: effects of vitamin supplementation
    Stanley Chia
    Department of Cardiology, National Heart Centre, 17 Hospital Avenue, Singapore 168752, Republic of Singapore
    Clin Sci (Lond) 108:65-72. 2005
    ..This endothelial vasomotor dysfunction is unaltered by vitamin supplementation...
  16. ncbi request reprint Bacteria and airway inflammation in chronic obstructive pulmonary disease: more evidence
    Robert Wilson
    Am J Respir Crit Care Med 172:147-8. 2005
  17. ncbi request reprint Multiple simultaneous complications of acute otitis media in a child diagnosed with chronic granulomatous disease: a case report
    Robert Wilson
    Department of Surgery, Division of Otolaryngology, University of Kentucky College of Medicine, 800 Rose St, Lexington, KY 40536 0298, USA
    Ear Nose Throat J 87:271-2, 279. 2008
    ..The presented case should encourage physicians to investigate the possibility of an underlying immunodeficiency when treating patients with multiple simultaneous complications of acute otitis media...
  18. doi request reprint Short course of antibiotic treatment in acute exacerbations of COPD
    Robert Wilson
    Thorax 63:390-2. 2008